Expected timeline: Month 1-2: Inflammation management, symptomatic improvement Month 3-6: Potential slowing of degenerative markers, quality of life improvement Month 6-12: Assessment of structural changes, protocol optimization Ongoing: Maintenance protocols as needed, cycling strategies Complementary approaches: Anti-inflammatory nutrition
Essential equipment Dedicated mini-fridge
[5] Preclinical Safety Evaluation of Body Protective Compound-157, a Potential Drug for Treating Various Wounds NIH
These substitutions can affect drug stability, absorption, and may trigger allergic reactions or other adverse effects
Makeup should not be applied to the skin for at least 12 hours after the Dermapen session
S. Seiwerthet al., Stable Gastric Pentadecapeptide BPC 157 and Wound Healing, Frontiers Media SA, Jun. 2021. doi: 10.3389/fphar.2021.627533